Since CXCL1 has been implicated in many neuroinflammatory disorders and their models, such as EAE, MS, other demyelinating diseases, neurodegeneration, and infection, being able to modulate its secretion at one of its sources may be a common solution to seemingly unrelated pathologies. This evidence concerns the gene CXCL1 and demyelinating disease.